1. Home
  2. NRXP vs BWEN Comparison

NRXP vs BWEN Comparison

Compare NRXP & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • BWEN
  • Stock Information
  • Founded
  • NRXP 2015
  • BWEN N/A
  • Country
  • NRXP United States
  • BWEN United States
  • Employees
  • NRXP N/A
  • BWEN N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • BWEN Industrials
  • Exchange
  • NRXP Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • NRXP 58.5M
  • BWEN 48.4M
  • IPO Year
  • NRXP N/A
  • BWEN N/A
  • Fundamental
  • Price
  • NRXP $2.84
  • BWEN $1.97
  • Analyst Decision
  • NRXP Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • NRXP 5
  • BWEN 1
  • Target Price
  • NRXP $31.40
  • BWEN $6.00
  • AVG Volume (30 Days)
  • NRXP 562.9K
  • BWEN 173.6K
  • Earning Date
  • NRXP 08-18-2025
  • BWEN 08-12-2025
  • Dividend Yield
  • NRXP N/A
  • BWEN N/A
  • EPS Growth
  • NRXP N/A
  • BWEN N/A
  • EPS
  • NRXP N/A
  • BWEN N/A
  • Revenue
  • NRXP N/A
  • BWEN $145,141,000.00
  • Revenue This Year
  • NRXP N/A
  • BWEN $8.75
  • Revenue Next Year
  • NRXP $231.16
  • BWEN $3.50
  • P/E Ratio
  • NRXP N/A
  • BWEN N/A
  • Revenue Growth
  • NRXP N/A
  • BWEN N/A
  • 52 Week Low
  • NRXP $1.10
  • BWEN $1.41
  • 52 Week High
  • NRXP $6.01
  • BWEN $3.03
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 56.21
  • BWEN 36.66
  • Support Level
  • NRXP $2.26
  • BWEN $1.95
  • Resistance Level
  • NRXP $2.81
  • BWEN $2.09
  • Average True Range (ATR)
  • NRXP 0.23
  • BWEN 0.13
  • MACD
  • NRXP 0.04
  • BWEN -0.02
  • Stochastic Oscillator
  • NRXP 78.38
  • BWEN 5.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: